Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares Outstanding
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to $29.0 million.

  • Enanta Pharmaceuticals' Shares Outstanding rose 3602.87% to $29.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.0 million, marking a year-over-year increase of 3602.87%. This contributed to the annual value of $21.4 million for FY2025, which is 91.06% up from last year.
  • According to the latest figures from Q4 2025, Enanta Pharmaceuticals' Shares Outstanding is $29.0 million, which was up 3602.87% from $21.4 million recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Shares Outstanding ranged from a high of $29.0 million in Q4 2025 and a low of $20.2 million during Q1 2021
  • For the 5-year period, Enanta Pharmaceuticals' Shares Outstanding averaged around $21.3 million, with its median value being $21.1 million (2023).
  • In the last 5 years, Enanta Pharmaceuticals' Shares Outstanding soared by 59.84% in 2024 and then soared by 3602.87% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Quarter) stood at $20.5 million in 2021, then rose by 1.84% to $20.9 million in 2022, then rose by 1.3% to $21.2 million in 2023, then rose by 0.84% to $21.3 million in 2024, then surged by 36.03% to $29.0 million in 2025.
  • Its Shares Outstanding was $29.0 million in Q4 2025, compared to $21.4 million in Q3 2025 and $21.4 million in Q2 2025.